Sartorius Stedim Japan K.K. Official site

NanoSpark STEM-T TCell Activator

Activation and proliferation of CAR-T cells targeting the proliferation of CD8+ cells aimed at obtaining high stem cell-like characteristics and therapeutic effects.

NanoSpark STEM-T T Cell Activator is a reagent available for immediate culture for the in vitro activation and proliferation of human T cells. NanoSpark STEM-T T Cell Activator is a self-assembling protein nanoparticle with anti-CD3 antibodies and anti-CD28 antibodies bound to its surface through high-affinity non-covalent interactions. The unique biophysical composition of the anti-CD3 and anti-CD28 antibodies present on the surface of the STEM-T nanoparticles induces strong primary and co-stimulatory signals that specifically activate and proliferate T cells, promoting the production of stem cell-like CD8+ T cells.

Related Link - https://www.sartorius.com/en/products/cell-culture…

basic information

Related Applications ■ T Cells | CAR-T Cells ■ Research and Manufacturing of Cancer Immunotherapy Related Process Steps ■ Activation and Proliferation of T Cells

Price range

Delivery Time

Applications/Examples of results

For more details, please refer to the PDF document or feel free to contact us.

NanoSpark STEM-T T Cell Activator

PRODUCT

NanoSpark GROW-NK Soluble Activator

PRODUCT

CellGenix Preclinical & GMP Cytokine Portfolio

PRODUCT

Resource Roadmap for Successful Screening: Cell Therapy Edition

APPLICATION_NOTE

Culture medium solution for gene cell therapy.

PRODUCT

Recommended products

Distributors

Sartorius Stedim, established in 2007 through the merger of the German company Sartorius, founded in 1870, and the French company Stedim, is a pioneer in "Single-Use Technology (SUT)." As a company capable of providing comprehensive technical support to the pharmaceutical and biotechnology industries, its cutting-edge technology is highly regarded worldwide in the fields of scientific instruments and biotechnology.